共 50 条
- [41] IS IT PRACTICAL TO DEVELOP A CLASS-III ANTIARRHYTHMIC AGENT RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 157 - 166
- [47] PREVENTION AND ALLEVIATION OF DEVELOPING CLASS-III MALOCCLUSION AMERICAN JOURNAL OF ORTHODONTICS AND ORAL SURGERY-ORTHODONTICS, 1945, 31 (05): : 269 - 278
- [49] MECHANISM OF ACTION OF CLASS-III ANTIARRHYTHMIC AGENTS ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1995, 88 : 33 - 40
- [50] SYNTHESIS AND CARDIAC ELECTROPHYSIOLOGICAL ACTIVITY OF ARYL SUBSTITUTED DERIVATIVES OF THE CLASS-III ANTIARRHYTHMIC AGENT SEMATILIDE - POTENTIAL CLASS-I CLASS-III AGENTS ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 198 : 70 - MEDI